Tuberous Sclerosis Complex research hub
3 indexed studies · 1 currently recruiting
- active not recruitingPHASE1, PHASE2
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
This study, called Astroscape, is testing a new medicine called radiprodil for children and young people aged 6 months to 18 years. It's for those with Tuberous Sclerosis Complex (TSC) or Focal Cortical Dysplasia (FCD Type II) who experience difficult-to-treat seizures.
Australia · Belgium · Canada - recruitingNA
Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)
This study looks into why some children and adults with a brain condition called Focal Cortical Dysplasia (FCD) get severe epilepsy. By studying brain tissue, blood, and nasal samples, researchers hope to find new causes and develop better ways to detect and treat this type of epilepsy.
United Kingdom - ongoing, recruitingTherapeutic exploratory (Phase II)
Open, randomized, IInd phase clinical study evaluating the safety and efficacy of rapamycin in the treatment of drug-resistant epilepsy in children with rare and ultra rare diseases of the central nervous system associated with the activation of the mTOR pathway : BraimTOR-NEURO
This study is looking at a medicine called rapamycin for children whose epilepsy is difficult to treat. We want to see how safe the medicine is and if it can reduce seizures in children with rare brain conditions linked to a specific pathway called mTOR.
Poland